Skip to content

Pharmaceutical Marketing Services

The constraint in pharma marketing is not creative. It is orchestration — getting field, digital, medical and events to reach the same physician with the same message inside a window where it compounds instead of colliding. Most organisations cannot see that they are failing at it, because each channel reports separately.

In short

Hibridge plans and delivers marketing programmes for prescription and consumer health brands across HCP and patient audiences. Work spans brand planning, omnichannel campaign design, detail aids and scientific materials, patient support and adherence programmes, KOL and medical education activity, and the measurement framework that links spend to prescribing behaviour.

What we do

HCP and patient programmes that survive review and move prescribing.

Brand planning

Positioning, message architecture, lifecycle strategy and the annual brand plan, built to be defensible in review rather than rewritten after it.

Omnichannel campaign design

Sequenced HCP journeys across field, email, web, closed-loop marketing and third-party media, timed so channels reinforce rather than duplicate.

HCP materials and detail aids

Scientific narrative, visual aids, leave-behinds and reprint carriers — referenced, on-label and pre-cleared.

Patient programmes

Adherence, education and support programmes designed inside local pharmacovigilance and data protection constraints.

Medical education and KOL

Speaker programmes, standalone education, and advisory engagement with fair-market-value discipline applied throughout.

Measurement

A metric framework agreed up front, tied to prescribing and access outcomes rather than impressions.

Approach

How the work runs

  1. 01

    Audit

    What is actually reaching your priority prescribers today, across every channel, in one view.

  2. 02

    Plan

    Message architecture and channel sequence, with compliance positions resolved during planning, not after.

  3. 03

    Produce

    Materials developed and pre-cleared internally before submission to your MLR process.

  4. 04

    Measure

    Monthly read against the agreed framework, with reallocation decisions made on evidence.

Why it matters

Synchronisation is the highest-leverage and most commonly missed variable in pharma marketing. The measured uplift from getting it right is large, and most organisations are not close.

65%

65% of HCP engagements are not synchronised across channels.

Veeva Systems (Veeva Pulse Field Trends Report) ·

60%

Within ten days, a rep meeting followed by a digital exposure is 30% more likely to result in a prescription. HCPs who also visit a brand website following a rep visit are 60% more likely to prescribe.

Veeva Systems (Veeva Pulse Field Trends Report) ·

23%

Synchronising digital marketing with field engagement increases marketing effectiveness by 23%.

Veeva Systems (Crossix + CRM data, 230+ US brands) ·

45%

Only 45% of healthcare professionals are accessible to biopharma companies, down from 60% eighteen months earlier. Half restrict engagement to three or fewer companies.

Veeva Systems (Veeva Pulse Field Trends Report) ·

Sources

Every figure on this page is attributed to its original publisher. Where a figure is organiser-reported or secondary, we say so.

  1. Veeva Systems (Veeva Pulse Field Trends Report) — Veeva Pulse Data Shows New Science Calls for More Connected Engagement ·
  2. Veeva Systems (Crossix + CRM data, 230+ US brands) — Biopharmas Boost Marketing Effectiveness by 23% by Synchronizing Digital Media with Field Engagement ·
  3. Veeva Systems (Veeva Pulse Field Trends Report) — New Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops ·

Frequently asked questions

Do you work on prescription brands, consumer health, or both?
Both. They run under different rules — promotional codes, claim substantiation and channel latitude all differ — so we scope them separately even inside the same portfolio.
Can you work with our existing creative agency?
Yes. A common arrangement is that we hold strategy, orchestration and compliance pre-clearance while an incumbent agency retains execution.
How do you measure marketing effectiveness in a market with limited script data?
By agreeing a proxy hierarchy up front — sales-out, tender wins, engagement depth on owned channels, field-reported behaviour change — and being explicit about the confidence level of each rather than implying precision we do not have.

Related services

Conference & Event Management

Congresses, symposia and advisory boards, run to pharma standards.

Conferences & Events

Go-To-Market & Product Launch

Launch sequencing built around what the market will actually reimburse.

Go-To-Market

Branding & Brand Strategy

Identity systems that hold across markets, languages and review.

Branding

Tell us what you are working on.

A launch, a congress, a portfolio that is not performing, or a compliance process that has become the bottleneck. We reply within one business day.

Start a conversationhello@hibridge.eg